Canada’s patent ‘utility’ regime on trial: Adrienne Blanchard for the MLI IP newsletter
The Supreme Court’s decision to hear AstraZeneca’s appeal and this month’s NAFTA hearings on an Eli Lilly complaint shine a ...
Tag: IP newsletter
Dodged bullet or missed opportunity with CHEO settlement?: Richard Owens for the MLI IP newsletter
While there was certainly a win on the costs of genetic testing, the long-term effects of Transgenomic’s departure from the ...
Stop the TPP-IP media pile-on: Richard Owens for the MLI IP newsletter
It has become fashionable to declare the Trans-Pacific Partnership intellectual property provisions a disaster for innovation in Canada, writes Richard ...
-
Time for an intervention – an urgent call to end “gender-affirming” treatments for children: J. Edward Les for Inside Policy
-
The Governor General deserves better, but we deserve impartiality: Philippe Lagassé for Inside Policy
-
Conservatives can reject destructive left-wing policies and still take climate change seriously: Brian Lee Crowley in the National Post
-
Success assured? Appraising the Canadian-led Enhanced Forward Presence battlegroup in Latvia
-
Widespread shortages, skyrocketing costs: the growing calamity that is government-controlled child care
